Idebenone, a Coenzyme Q10 analogue, primarily used for neurocognitive disorders such as Alzheimer’s disease, was also shown to have pro-apoptotic effects [74]. Here, AGO2 is linked to early-onset autosomal dominant Alzheimer disease.